The experiment was said to have taken place in October 2018, but the Soyuz MS-10 spacecraft, carrying cosmonaut Alexey Ovchinin and the bioprinter, suffered a booster failure that forced the crew to crash. Both Ovchinin and astronaut Nick Hague escaped safely, but the printer was severely damaged. A backup was prepared quickly and the new crew including Kononenko was trained in the application. They started again on the ISS on December 3, and shortly afterwards the bioprinting experiments began.
Roscosmos, Russia's equivalent of NASA, rarely works with private companies, but will do much more in the future. NASA is also planning bioprint experiments in the first half of 2019, but Russia has the rights to go first.
After the first living tissue has been created, the next step is to see how microgravity in the ISS influenced its evolution. The biological material printed in space was launched aboard the Soyuz MS-09 on December 20 (along with NASA astronaut Serena Auñón-Chancellor, German astronaut Alexander Gerst of the European Space Agency, and Russian cosmonaut Sergey Prokopyev) returned. Roscosmos said test results will be announced sometime in January 2019.